Drs. Sharon Cresci and Richard Bach of the Washington University School of Medicine Hypertrophic Cardiomyopathy Center acted as moderators at the 2023 Hypertrophy Cardiomyopathy Society (HCMS) Scientific Sessions in Cleveland, Ohio.
Dr. Cresci moderated a panel discussion entitled “I’ve found the intermediate biomarker of HCM disease progression!”, and Dr. Bach moderated the lecture session “Defining quality HCM care in 2023; SRT and more”.
The Hypertrophic Cardiomyopathy Medical Society (HCMS) exists to bring together an innovative and productive community of physicians, scientists and medical providers dedicated to improving the diagnosis and treatment of people with hypertrophic cardiomyopathy through clinical excellence, research and education.